This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Health Care & Hospital Law,
Civil Litigation

Nov. 3, 2021

Plaintiffs to seek review of lost $52B suit against opioid makers

Reacting to the ruling, the pharmaceutical companies said their marketing of opioids such as Oxycontin, Kadian, and Duragesic, were entirely legal and appropriate, as the judge had said in his ruling.

After an Orange County judge tentatively ruled four major drug companies were not liable for the state's opioid crisis, a plaintiffs committee seeking $52 billion on behalf of the state, vowed to appeal the decision.

"The people of California will have their opportunity to pursue justice on appeal and ensure no opioid manufacturer can engage in reckless corporate practices that compromise public health in the state for their own profit," T...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up